Effect of WIN 64338, a B2 bradykinin receptor antagonist on guinea-pig tracheal smooth muscle cells in culture

被引:4
|
作者
Scherrer, D [1 ]
Schmidlin, F [1 ]
Lach, E [1 ]
Da Silva, A [1 ]
Landry, Y [1 ]
Gies, JP [1 ]
机构
[1] Univ Louis Pasteur Strasbourg 1, Fac Pharm, INSERM,U425, Lab Neuroimmunopharmacol, F-67401 Illkirch Graffenstaden, France
关键词
bradykinin; WIN; 64338; tracheal smooth muscle cell culture;
D O I
10.1111/j.1472-8206.1998.tb00940.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
This study investigated the effect of the non-peptidic B-2 bradykinin (BK) receptor antagonist WIN 64338 on BK binding and BK-induced inositol phosphate formation on guinea-pig tracheal smooth muscle cells in culture. The presence of specific and saturable binding sites for BK was demonstrated using [H-3]BK. Scatchard analysis indicates a single population of binding sites for [H-3]BK with a maximal density (B-max) of 245.4 +/- 71 fmol/mg of protein and an equilibrium dissociation constant (K-d) of 87.7 +/- 0.12 pM. The order of potency of B-2 BK receptor ligands was Hoe 140 = NPC 17731 > BK > WIN 64338 > D-Arg(0)[Hyp(3), D-Phe(7)]-BK > > des-Arg(9)-BK, while the B-1 BK receptor antagonist, des-Arg(9)-[Leu(8)]-BK, was without effect on [3H]BK binding. These results demonstrate the presence of B-2 BK receptors on cultured tracheal smooth muscle cells. The cells were stimulated by BK, and inositol phosphate formation was determined by anion exchange chromatography. The stimulating effect of BK on inositol phosphate formation was concentration dependent (1 nM to 10 mu M). The B-1 BK agonist des-Arg(9)-BK did not induce inositol phosphate formation. The order of potency of B-2 antagonists to inhibit BK-induced inositol phosphate formation was Hoe 140 = NPC 17731 > WIN 64338 > D-Arg(0)[Hyp(3), D-Phe(7)]-BK. This study demonstrates that WIN 64338 is able to displace [H-3]BK binding and to inhibit B-2-BK-induced inositol phosphate formation on cultured guinea-pig tracheal smooth muscle cells. (C) 1998 Elsevier, Paris.
引用
收藏
页码:188 / 193
页数:6
相关论文
共 50 条
  • [31] Icatibant, the bradykinin B2 receptor antagonist with target to the interconnected kinin systems
    Charignon, Delphine
    Spaeth, Peter
    Martin, Ludovic
    Drouet, Christian
    EXPERT OPINION ON PHARMACOTHERAPY, 2012, 13 (15) : 2233 - 2247
  • [32] Antagonist-induced intracellular sequestration of rabbit bradykinin B2 receptor
    Houle, S
    Larrivée, JF
    Bachvarova, M
    Bouthillier, J
    Bachvarov, DR
    Marceau, F
    HYPERTENSION, 2000, 35 (06) : 1319 - 1325
  • [33] Effect of bradykinin on bradykinin-B2 receptor in rat aortic vascular smooth muscle cells and the involved signal transduction pathways
    Yan W.
    Feng M.
    Wang P.-H.
    Wang D.-W.
    Frontiers of Medicine in China, 2010, 4 (2): : 225 - 228
  • [34] Role of bradykinin B2 receptors in the modulation of the peristaltic reflex of the guinea pig isolated ileum
    Chan, Siu Ki
    Rudd, John A.
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2006, 539 (1-2) : 108 - 115
  • [35] Helokinestatin:: A new bradykinin B2 receptor antagonist decapeptide from lizard venom
    Kwok, Hang Fai
    Chen, Tianbao
    O'Rourke, Martin
    Ivanyi, Craig
    Hirst, David
    Shaw, Chris
    PEPTIDES, 2008, 29 (01) : 65 - 72
  • [36] LF 16.0335, a novel potent and selective nonpeptide antagonist of the human bradykinin B2 receptor
    Pruneau, D
    Luccarini, JM
    Fouchet, C
    Defrêne, E
    Franck, RM
    Loillier, B
    Duclos, H
    Robert, C
    Cremers, B
    Bélichard, P
    Paquet, JL
    BRITISH JOURNAL OF PHARMACOLOGY, 1998, 125 (02) : 365 - 372
  • [37] A non-peptide antagonist unusually selective for the human form of the bradykinin B2 receptor
    Marceau, F
    Fortin, JP
    Morissette, G
    Dziadulewicz, EK
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2003, 3 (10-11) : 1529 - 1536
  • [38] The angiotensin II type 1 receptor antagonist Losartan binds and activates bradykinin B2 receptor signaling
    Bonde, Marie Mi
    Olsen, Kristine Boisen
    Erikstrup, Niels
    Speerschneider, Tobias
    Lyngso, Christina
    Haunso, Stig
    Nielsen, Morten Schak
    Sheikh, Soren P.
    Hansen, Jakob Lerche
    REGULATORY PEPTIDES, 2011, 167 (01) : 21 - 25
  • [39] EFFECT OF HOE-140, A NEW BRADYKININ RECEPTOR ANTAGONIST, ON BRADYKININ-ACTIVATING AND PLATELET-ACTIVATING FACTOR-INDUCED BRONCHOCONSTRICTION AND AIRWAY MICROVASCULAR LEAKAGE IN GUINEA-PIG
    SAKAMOTO, T
    ELWOOD, W
    BARNES, PJ
    CHUNG, KF
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1992, 213 (03) : 367 - 373
  • [40] BRADYKININ INHIBITS ADENYLATE-CYCLASE ACTIVITY IN GUINEA-PIG ILEUM MEMBRANES VIA A SEPARATE HIGH-AFFINITY BRADYKININ B-2 RECEPTOR
    LIEBMANN, C
    MAMMERY, K
    GRANESS, A
    EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION, 1994, 288 (01): : 35 - 43